Economic burden of anal cancer management in France;Poids économique de la prise en charge du cancer anal en France.

Revue d'Epidemiologie et de Sante Publique

Volumn 58, Issue 5, 2010, Pages 331-338

  Abramowitz, L ^a   Remy V ^b   Vainchtock, A ^c  

^a BICHAT HOSPITAL   (France)

^b SANOFI PASTEUR   (France)

^c HEVA   (France)

Author keywords

Anal cancer; Cost; Epidemiology; France; Human papillomavirus

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANUS CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER SURGERY; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST OF ILLNESS; DISEASE ASSOCIATION; ECONOMIC EVALUATION; FEMALE; FRANCE; HEALTH CARE QUALITY; HOSPITAL COST; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; PATIENT CARE; PATIENT IDENTIFICATION; PRIVATE HOSPITAL; PUBLIC HOSPITAL; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANUS NEOPLASMS; FEMALE; FRANCE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 78149414492     PISSN: 03987620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.respe.2010.06.165     Document Type: Article

References (24)

1. Uronis H.E., Bendell J.C. Anal cancer: an overview. Oncologist 2007, 12:524-534.
2. Abbasakour F., Boulos P.B. Anal intraepithelial neoplasia. Br J Surg 2005, 92:277-290.
3. Melbye M., Frisch M. The role of human papillomaviruses in anogenital cancers. Cancer Biol 1998, 8:307-313.
4. Daling J.R., Madeleine M.M., Johnson L.G., Schwartz S.M., Shera K.A., Wurscher M.A., et al. Human papillomavirus, smoking and sexual practices in the etiology of anal cancer. Cancer 2004, 101:270-280.
5. Palmer J.G., Scholefield J.H., Coates P.J., Shepherd N.A., Jass J.R., Crawford L.V., et al. Anal cancer and human papillomaviruses. Dis Colon Rectum 1989, 32:1016-1022.
6. De Vuyst H., Clifford G.M., Nascimento M.C., Madeleine M.M., Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009, 124(7):1626-1636.
7. Herat A., Whitfield M., Hillman R. Anal intraepithelial neoplasia and anal cancer in dermatological practice. Australas J Dermatol 2007, 48:143-155.
8. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. Cancer incidence in five continents, Vol. IX. IARC Scientific Publications No. 160. Lyon, France: IARCPress; 2007 [; accessed 2 February 2009]. http://www.dep.iarc.fr/CI5-IX/PDF/BYSITE/S_C21.pdf.
9. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, et al. SEER cancer statistics review, 1975-2005. Bethesda, MD: National Cancer Institute; 2007 [, based on November 2007 SEER data submission, posted to the SEER web site, 2008; accessed 2 February 2009]. http://www.seer.cancer.gov/csr/1975_2005/.
10. Parkin M.D., Bray F. Chapter 2. The burden of HPV-related cancers. Vaccine 2006, 24(Suppl. 3):S11-S25.
11. Brewster D.H., Bhatti L.A. Increasing incidence of squamous cell carcinoma of the anus in Scotland, 1975-2002. Br J Cancer 2006, 95:87-90.
12. Johnson L.G., Madeleine M.M., Newcomer L.M., Schwartz S.M., Daling J.R. Anal cancer incidence and survival: the Surveillance. Epidemiology and end results experience, 1973-2000. Cancer 2004, 101:281-288.
13. PMSI. Programme de médicalisation des systèmes d'information [In French] [; accessed 2 February 2009]. http://www.atih.sante.fr/%3Fid=000000000000.
14. SAE database. Statistiques annuelles des établissements de santé [In French]. 2006 [; accessed 2 February 2009]. http://www.sae-diffusion.sante.gouv.fr/.
15. Arrêté du 27 février 2007 fixant pour l'année 2007 les ressources d'assurance maladie des établissements de santé exerçant une activité de médecine, chirurgie, obstétrique et odontologie. Texte No. 17. Journal officiel de la République française 2007;54:4090 [In French] [, accessed 10 September 2009]. http://www.legifrance.gouv.fr/affichTexte.do%3FcidTexte=JORFTEXT000000271206%26dateTexte=
16. BAQIMEHP. Bureau de l'assurance qualité et de l'information médico-2conomique de l'hospitalisation privée. 2004 [; accessed 2 February 2009]. http://www.baqimehp.com/index.asp.
17. Weill A., Chinaud F., Vallier N., Bourrel R., Suarez C., Cayla M., et al. Frequency and cost of thirty long-term disorders in the Midi-Pyrénées region in 2003. Rev Med Assurance Maladie 2005, 36:273-287. [In French].
18. Analyse économique du cout du cancer en France 2007, INCA, Institut National du Cancer, Boulogne-Billancourt, France.
19. Insinga R.P., Ye X., Singhal P.K., Carides G.W. Healthcare resource use and costs associated with cervical, vaginal and vulvar cancers in a large US health plan. Gynecol Oncol 2008, 111:188-196.
20. Denis P. Épidémiologie et conséquences médico-économiques de l'incontinence anale de l'adulte. e-Memoires Acad Natl Chir 2005, 4:15-20. [In French].
21. Miner P.B. Economic and personal impact of fecal and urinary incontinence. Gastroenterol 2004, 126(1 Suppl. 1):S8-S13.
22. Tariq S.H. Fecal incontinence in older adults. Clin Geriatr Med 2007, 23:857-869.
23. Lahr C.J. Evaluation and treatment of incontinence. Pract Gastroenterol 1988, 12:27.
24. Hampl M., Sarajuuri H., Wentzensen N., Bender H.G., Kueppers V. Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and anal cancer. Obstet Gyn 2006, 108:1361-1368.